Resveratrol: A review of preclinical studies for human cancer prevention
Top Cited Papers
- 3 January 2007
- journal article
- review article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 224 (3) , 274-283
- https://doi.org/10.1016/j.taap.2006.12.025
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53Biochemical and Biophysical Research Communications, 2005
- Resveratrol‐induced apoptosis in MCF‐7 human breast cancer cells involves a caspase‐independent mechanism with downregulation of Bcl‐2 and NF‐κBInternational Journal of Cancer, 2005
- Resveratrol interference with the cell cycle protects human neuroblastoma SH-SY5Y cell from paclitaxel-induced apoptosisNeurochemistry International, 2005
- Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damageBiochemical Journal, 2004
- Resveratrol modulates the phosphoinositide 3‐kinase pathway through an estrogen receptor α‐dependent mechanism: Relevance in cell proliferationInternational Journal of Cancer, 2003
- Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyreneJournal of Applied Toxicology, 2003
- Effect of Resveratrol on Growth of 4T1 Breast Cancer Cells in Vitro and in VivoBiochemical and Biophysical Research Communications, 2002
- Botanical antioxidants for chemoprevention of photocarcinogenesisFrontiers in Bioscience-Landmark, 2002
- Effect of Resveratrol on the Expression of Autocrine Growth Modulators in Human Breast Cancer CellsAntioxidants and Redox Signaling, 2001
- Resveratrol, a Natural Product Present in Wine, Decreases Tumour Growth in a Rat Tumour ModelBiochemical and Biophysical Research Communications, 1999